AbbVie joins BMS in taking a hard line on UK drug pricing AbbVie has said it may not launch its ovarian cancer therapy Elahere in the UK if a viable NHS price cannot be agreed with NICE.

#AbbVie #BMS #BristolMyersSquibb #UKdrugpricing #pharmagroup #newmedicines #UK #USA #ovariancancertherapy #Elahere #NHSpatients #reimbursementauthority #NICE #schizophrenia #Cobenfy #pharmacompanies #Trump #medicineprices #MHRA #VPAG #rebates #NHS #MSD #EliLilly #AstraZeneca
zurl.co/d8CQZ

AbbVie Unveils ELAHERE® Pricing Strategy for UK Market, Equal to US AbbVie has announced a pricing strategy for ELAHERE® in the UK, aligning its costs with those in the US to extend its innovative cancer treatment to more patients.

AbbVie Unveils ELAHERE® Pricing Strategy for UK Market, Equal to US #United_Kingdom #AbbVie #North_Chicago #Ovarian_Cancer #ELAHERE

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌

Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.

#Onco404 #Cancer #Kanser #MedSky #AntibodyDrugConjugate #ADC #Enhertu #Trodelvy #Padcev #Kadcyla #Elahere #Mylotarg #Polivy #Vocabulary

ELAHERE® Shows Promising Long-Term Survival Benefits for Ovarian Cancer Patients Recent trial results indicate that ELAHERE® significantly improves the survival rates of patients with platinum-resistant ovarian cancer compared to traditional chemotherapy treatments.

ELAHERE® Shows Promising Long-Term Survival Benefits for Ovarian Cancer Patients #USA #AbbVie #North_Chicago #Ovarian_Cancer #ELAHERE